James Patla serves as an executive at Sheikh Khalifa General Hospital, overseeing strategic initiatives and leadership responsibilities.
| Company | Designation | Period |
|---|---|---|
| GEMS Education | Chief Financial Officer | Sep 2006 – Jun 2007 |
| STERIS Corporation | VP Healthcare Europe, Middle East & Africa | Sep 2003 – Sep 2006 |
| Enaya Healthcare | Chief Financial Officer | Nov 2008 – Jun 2009 |
| Welcare World Health Systems | Chief Executive Officer | Nov 2006 – Dec 2007 |
| Sheikh Khalifa Specialist Hospital | Chief Financial Officer | Mar 2013 – Aug 2013 |
| Al Rahba Hospital (Managed by Johns Hopkins Medical International) | CFO | Jun 2009 – Sep 2012 |
| Private Practice | Consultant | Jan 2008 – Oct 2008 |
| Boston Scientific | VP Scimed Europe | Jan 2001 – Jan 2003 |
| Boston Scientific | Europe Controller | Jan 1996 – Jan 2001 |
| GE Medical Systems Latin America | Manager Finance | Jan 1995 – Jan 1996 |
| GE Medical Systems Latin America | Manager Finance | Jan 1994 – Jan 1995 |
| GE Medical Systems Latin America | Manager Financial Planning & Analysis | Jan 1991 – Jan 1994 |
| Yokogawa Medical Systems | Manager Finance | Jan 1988 – Jan 1991 |
| GE Medical Systems Latin America | Manager Finance | Jan 1973 – Jan 1996 |
| Sheikh Khalifa General Hospital | CFO | Oct 2013 – Present |
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Official Email: Via Sheikh Khalifa General Hospital corporate communication desk.
Personal Contact: Not publicly disclosed.
What is James Patla's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Sheikh Khalifa General Hospital's official communication channels.
Is this an official profile?
No — independently created using public data.
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)